Resources

Useful resources if you want to find out more

Mechanisms for Delaying/Preventing Type 1 Diabetes Clinical Onset

Learn how anti-CD3 monoclonal activities can delay/prevent clinical T1D in patients at risk of developing the disease – new treatment strategies for T1D. (Registration on Medscape Education is free, please create an account to access presentation video).

Changing the Course of the River

A video that Colin Dayan did at a JDRF Type 1 Diabetes Discovery meeting on 11th Feb 2021.

Immunotherapy Treatment for Type 1 Diabetes

Colin Dayan explains immunotherapy for T1D – here interviewed by Vivienne Parry OBE prior to a plenary lecture at the EASD in Berlin Sept 2018.

Richard Leslie on clinical management of t1duk

Clinical Management of Adult-onset Type 1 Diabetes

Presented to the Chinese Endocrine Association in June 2021 by Professor Richard David Leslie.

Immunotherapy to stop type 1 diabetes

Hear from our researcher Professor Colin Dayan about exciting new treatments on the horizon for type 1 diabetes, called immunotherapies.

Why do we need more than insulin injections?

The discovery of insulin in 1921 by Banting & Best was considered a miracle. However, nearly a century later, and despite considerable advances in insulin therapy, insulin delivery and education, patients with type 1 diabetes still have a reduced life expectancy and many have a high risk of developing long-term complications.

Prof Colin Dayan, Professor in Clinical Diabetes & Metabolism at Cardiff University, explains why insulin isn’t enough, why we need more than insulin to treat and manage type 1 diabetes and how better blood glucose control may be achieved through preserving the body’s own insulin production.

Watch the Video

Immunotherapy in type 1 diabetes – What is it?

Immunotherapy in type 1 diabetes aims to reduce the damage to insulin making beta cells caused by the immune system, thereby preserving the body’s ability to make it’s own insulin.

Prof Colin Dayan, Professor in Clinical Diabetes & Metabolism at Cardiff University explains all about immunotherapy in type 1 diabetes; the different types of immunotherapy, how immunotherapy is given, gives examples of current day immunotherapies and discusses the potential benefits of these newer treatments in managing and treating type 1 diabetes.

Watch the Video

DigiBete.org is a not-for-profit Type 1 Diabetes Platform and App for Children and Young people supported centrally by NHS England, Scotland and Wales. All resources are freely available to families and communities managing diabetes in up to 99 languages.

What is Type 1 Diabetes?

Type 1 diabetes is an autoimmune disease which occurs when the body’s own immune system which normally protects against illness and infection, turns against itself and attacks the insulin-producing beta cells in the pancreas.

To find out more click on the following links:

https://www.diabetes.org.uk/Guide-to-diabetes/What-is-diabetes/

https://jdrf.org.uk/about-type-1-diabetes/

Type 1 Diabetes Resources

A selection of online resources to make type 1 diabetes a little easier to live with – checked and reviewed by both healthcare professionals and people with diabetes.